# European Urology Oncology

**Type:** Journals  
**Canonical URL:** https://scholariq.org/journals/european-urology-oncology/

## Facts

| Field | Value |
| --- | --- |
| Open Access | false |
| ISSN-L | 2588-9311 |
| ISSNs | 2588-9311 |
| OpenAlex ID | https://openalex.org/S2898501490 |
| Publisher | Elsevier BV |

## Journal papers

- [Poor Outcomes for Patients with Metastatic Castration-resistant Prostate Cancer with Low Prostate-specific Membrane Antigen (PSMA) Expression Deemed Ineligible for 177Lu-labelled PSMA Radioligand Therapy](https://scholariq.org/papers/poor-outcomes-for-patients-with-metastatic-castration-resistant-prostate-cancer/)
- [Three-dimensional Model–assisted Minimally Invasive Partial Nephrectomy: A Systematic Review with Meta-analysis of Comparative Studies](https://scholariq.org/papers/three-dimensional-model-assisted-minimally-invasive-partial-nephrectomy-a/)
- [Standardising the Assessment of Patient-reported Outcome Measures in Localised Prostate Cancer. A Systematic Review](https://scholariq.org/papers/standardising-the-assessment-of-patient-reported-outcome-measures-in-localised/)
- [Comparative Effectiveness of Non-cisplatin First-line Therapies for Metastatic Urothelial Carcinoma: Phase 2 IMvigor210 Study Versus US Patients Treated in the Veterans Health Administration](https://scholariq.org/papers/comparative-effectiveness-of-non-cisplatin-first-line-therapies-for-metastatic/)
- [Current Treatment Paradigms and Clinical Outcomes in Oligometastatic Prostate Cancer Patients: A Targeted Literature Review](https://scholariq.org/papers/current-treatment-paradigms-and-clinical-outcomes-in-oligometastatic-prostate/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.